197 related articles for article (PubMed ID: 12160136)
21. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
[TBL] [Abstract][Full Text] [Related]
22. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
23. Spinal extramedullary anaplastic ependymoma with spinal and intracranial metastases.
Schuurmans M; Vanneste JA; Verstegen MJ; van Furth WR
J Neurooncol; 2006 Aug; 79(1):57-9. PubMed ID: 16614942
[TBL] [Abstract][Full Text] [Related]
24. Prognosis by tumor location for pediatric spinal cord ependymomas.
Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
[TBL] [Abstract][Full Text] [Related]
25. Tumours in Iceland. 15. Ependymoma. A clinicopathological and immunohistological study.
Birgisson S; Blöndal H; Björnsson J; Olafsdottir K
APMIS; 1992 Apr; 100(4):294-300. PubMed ID: 1581038
[TBL] [Abstract][Full Text] [Related]
26. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
Manasa LP; Uppin MS; Sundaram C
Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
[TBL] [Abstract][Full Text] [Related]
27. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas.
Parker JR; Armstrong DL; Strother D; Rudman DM; Dauser RC; Laurent JP; Deyd J; Rouah PE
J Child Neurol; 2001 Aug; 16(8):548-52. PubMed ID: 11510923
[TBL] [Abstract][Full Text] [Related]
28. Giant cell ependymoma-report of three cases and review of the literature.
Li JY; Lopez JI; Powell SZ; Coons SW; Fuller GN
Int J Clin Exp Pathol; 2012; 5(5):458-62. PubMed ID: 22808300
[TBL] [Abstract][Full Text] [Related]
29. Disseminated ependymomas of the central nervous system.
Rezai AR; Woo HH; Lee M; Cohen H; Zagzag D; Epstein FJ
J Neurosurg; 1996 Oct; 85(4):618-24. PubMed ID: 8814165
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
31. Concomitant localization of a myxopapillary ependymoma at the middle thoracic part of the spinal cord and at the distal part of the filum terminale. Case report.
De Falco R; Scarano E; Di Celmo D; Civetta F; Guarnieri L
J Neurosurg Sci; 2008 Sep; 52(3):87-91. PubMed ID: 18636054
[TBL] [Abstract][Full Text] [Related]
32. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
33. Intramedullary clear cell ependymoma in the thoracic spinal cord: a case with its crush smear and ultrastructural findings.
Kim NR; Chung DH; Lee SK; Ha SY
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S149-53. PubMed ID: 17923743
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic features of anaplastic myxopapillary ependymomas.
Lee JC; Sharifai N; Dahiya S; Kleinschmidt-DeMasters BK; Rosenblum MK; Reis GF; Samuel D; Siongco AM; Santi M; Storm PB; Ferris SP; Bollen AW; Pekmezci M; Solomon DA; Tihan T; Perry A
Brain Pathol; 2019 Jan; 29(1):75-84. PubMed ID: 30417460
[TBL] [Abstract][Full Text] [Related]
36. Cytologic features of ependymomas in smear preparations.
Ng HK
Acta Cytol; 1994; 38(3):331-4. PubMed ID: 8191821
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclo-oxygenase-2 in ependymal tumors.
Roma AA; Prayson RA
Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
Onguru O; Kurt B; Gunhan O; Soylemezoglu F
Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
[TBL] [Abstract][Full Text] [Related]
39. [MRI symptomatology of primary intraspinal cord gliomas].
Joubert E; Idir AB; Carlier R; Belal N; Hurth M; Lacroix-Ciaudo C; Ducot B; Doyon D
J Neuroradiol; 1995 Mar; 22(1):28-42. PubMed ID: 7707132
[TBL] [Abstract][Full Text] [Related]
40. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
